van Besouw N M, Daane C R, Vaessen L M, Balk A H, Claas F H, Zondervan P E, Jutte N H, Weimar W
Department of Internal Medicine, Erasmus University Rotterdam, The Netherlands.
J Heart Lung Transplant. 1995 Sep-Oct;14(5):816-23.
Cytokines play an important role in allograft rejection. The local production of cytokines by T-helper 2 cells within an allograft could influence the induction of graft rejection.
Therefore we studied the in vitro production of cytokines by cells infiltrating the graft. graft-infiltrating cell cultures derived from human endomyocardial biopsy specimens more often produced interleukin-2 (p < 0.001), interferon-gamma (p < 0.001), interleukin-4 (p = 0.02), and interleukin-6 (p = 0.04) after stimulation with a B-cell line obtained from the heart donor than after stimulation with a third-party B-cell line. Furthermore, the levels of these cytokines were significantly higher after donor stimulation than after third-party stimulation (p < 0.001).
Within the first 90 days after heart transplantation, significantly higher levels of interleukin-2 (p = 0.050 and interferon-gamma (p = 0.02) were produced by donor-stimulated lymphocyte cultures derived from biopsy specimens taken during a rejection episode compared with cultures from biopsy specimens taken during a period without rejection. After 90 days, the levels of T-helper 1 cytokine (interleukin-2 and interferon-gamma) production were, irrespective of the rejection grade, comparable with those found in the cultures from rejection biopsy specimens taken early after transplantation. With regard to T-helper 2 cytokines (interleukin-4 and interleukin-6), no relation was found with the presence of rejection at any time after transplantation.
These data suggest that in the first 3 months after heart transplantation, acute rejection is associated with the production of increased levels of T-helper 1 cytokines but not of T-helper 1 cytokines but not of T-helper 2 cytokines by donor stimulated graft-infiltrating lymphocytes. Thereafter, the T-helper 1 cytokine production of graft-infiltrating lymphocytes remained high, suggesting a continuous state of immunologic activity even in the absence of rejection.
细胞因子在同种异体移植排斥反应中起重要作用。同种异体移植物内辅助性T2细胞产生的细胞因子可能会影响移植排斥反应的诱导。
因此,我们研究了浸润移植物的细胞在体外产生细胞因子的情况。来自人类心内膜活检标本的移植物浸润细胞培养物在用从心脏供体获得的B细胞系刺激后,比用第三方B细胞系刺激后更常产生白细胞介素-2(p < 0.001)、干扰素-γ(p < 0.001)、白细胞介素-4(p = 0.02)和白细胞介素-6(p = 0.04)。此外,供体刺激后这些细胞因子的水平明显高于第三方刺激后(p < 0.001)。
在心脏移植后的前90天内,与无排斥反应期间活检标本的培养物相比,来自排斥反应发作期间活检标本的供体刺激淋巴细胞培养物产生的白细胞介素-2(p = 0.050)和干扰素-γ(p = 0.02)水平明显更高。90天后,辅助性T1细胞因子(白细胞介素-2和干扰素-γ)的产生水平,无论排斥反应等级如何,都与移植后早期排斥反应活检标本培养物中的水平相当。关于辅助性T2细胞因子(白细胞介素-4和白细胞介素-6),在移植后任何时间都未发现与排斥反应的存在有相关性。
这些数据表明,在心脏移植后的前3个月,急性排斥反应与供体刺激的移植物浸润淋巴细胞产生的辅助性T1细胞因子水平升高有关,但与辅助性T2细胞因子无关。此后,移植物浸润淋巴细胞的辅助性T1细胞因子产生仍然很高,这表明即使在没有排斥反应的情况下,免疫活性也处于持续状态。